Teva's CGRP Migraine Med Hits a Stumbling Block Post author:Sam Post published:February 8, 2018 Post category:BioPharma It’s starting to feel like Teva can’t catch a break. Source: BioSpace You Might Also Like As Its CEO Retires, Cerecor Divests Depression Drug to Pharma Giant in $45 Million Deal August 14, 2017 Bridging Clinical Research & Clinical Health Care: How to Improve Patient Centricity January 8, 2018 Aimmune Appoints As Chief Financial Officer April 12, 2017
As Its CEO Retires, Cerecor Divests Depression Drug to Pharma Giant in $45 Million Deal August 14, 2017
